 |
Researchers report that daclizumab alone or in combination with interferon beta reduced disease activity on MRI and improved symptoms in nine people with relapsing-remitting multiple sclerosis.
John W. Rose, MD and colleagues (University of Utah, Salt Lake City) report their findings in the August 21 issue of Neurology (2007;69:785-789).
To read more, please click on the link below.
Source: US National MS Society
Weblink: click here
|
